BCL2L12 and central nervous system cancer: SNA uptake into glioma cells was associated with a reduction in Bcl2L12 protein expression and induction of active caspase-3 and p53 proteins, suggesting that the uptake of NU-0129 into tumor cells translated into target knockdown and induction of p53 tumor-suppressive activity [48].